Captopril increases the intensity of monocyte infection by Trypanosoma cruzi and induces human T helper type 17 cells

Clinical and Experimental Immunology

Volumn 162, Issue 3, 2010, Pages 528-536

  Coelho dos Santos, J S ^a   Menezes, C A S ^a   Villani, F N A ^a   Magalhaes L M D ^a   Scharfstein, J ^c   Gollob, K J ^b,d,e   Dutra, W O ^a,d  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b Santa Casa Hospital   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d National Institute for Science and Technology in Tropical Diseases   (Brazil)

^e SRI INTERNATIONAL   (United States)

Author keywords

Captopril; Chagas disease; Monocytes; Th17; Trypanosoma cruzi

Indexed keywords

BRADYKININ B2 RECEPTOR; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; INTERLEUKIN 10; INTERLEUKIN 17; AUTACOID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CHAGAS DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME INDUCTION; HOST PARASITE INTERACTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MONOCYTE; NONHUMAN; PARASITISM; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE SUBPOPULATION; TH17 CELL; TRYPANOSOMA CRUZI; BIOSYNTHESIS; CELL CULTURE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; MALE; METABOLISM; PARASITOLOGY; PATHOGENICITY; PATHOLOGY; PATHOPHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TH1 TH2 BALANCE; VIRULENCE;

ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CAPTOPRIL; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CHAGAS DISEASE; GENE EXPRESSION REGULATION; HOST-PARASITE INTERACTIONS; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-10; INTERLEUKIN-17; MALE; MONOCYTES; RENIN-ANGIOTENSIN SYSTEM; TH1-TH2 BALANCE; TRYPANOSOMA CRUZI; VIRULENCE;

EID: 79952479931     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2010.04270.x     Document Type: Article

References (38)

1. Rassi A Jr, Rassi A, Marin-Neto JA. Chagas disease. Lancet 2010; 375:1388-402.
2. Marin-Neto JA, Cunha-Neto E, Maciel BC, Simoes MV. Pathogenesis of chronic Chagas heart disease. Circulation 2007; 115:1109-23.
3. Batlouni M, Barretto AC, Armaganijan D et al. [Treatment of mild and moderate cardiac failure with captopril. A multicenter study]. Arq Bras Cardiol 1992; 58:417-21.
4. Leon JS, Wang K, Engman DM. Captopril ameliorates myocarditis in acute experimental Chagas disease. Circulation 2003; 107:2264-9.
5. Bahk TJ, Daniels MD, Leon JS, Wang K, Engman DM. Comparison of angiotensin converting enzyme inhibition and angiotensin II receptor blockade for the prevention of experimental autoimmune myocarditis. Int J Cardiol 2008; 125:85-93.
6. Godsel LM, Leon JS, Engman DM. Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists in experimental myocarditis. Curr Pharm Des 2003; 9:723-35.
7. Skidgel RA, Erdos EG. Angiotensin converting enzyme (ACE) and neprilysin hydrolyze neuropeptides: a brief history, the beginning and follow-ups to early studies. Peptides 2004; 25:521-5.
8. Regoli D, Barabe J. Pharmacology of bradykinin and related kinins. Pharmacol Rev 1980; 32:1-46.
9. Scharfstein J, Schmitz V, Svensjo E, Granato A, Monteiro AC. Kininogens coordinate adaptive immunity through the proteolytic release of bradykinin, an endogenous danger signal driving dendritic cell maturation. Scand J Immunol 2007; 66:128-36.
10. Chen BC, Yu CC, Lei HC et al. Bradykinin B2 receptor mediates NF-kappaB activation and cyclooxygenase-2 expression via the Ras/Raf-1/ERK pathway in human airway epithelial cells. J Immunol 2004; 173:5219-28.
11. Maruo K, Akaike T, Ono T, Maeda H. Involvement of bradykinin generation in intravascular dissemination of Vibrio vulnificus and prevention of invasion by a bradykinin antagonist. Infect Immun 1998; 66:866-9.
12. Murta AC, Persechini PM, Padron Tde S, de Souza W, Guimaraes JA, Scharfstein J. Structural and functional identification of GP57/51 antigen of Trypanosoma cruzi as a cysteine proteinase. Mol Biochem Parasitol 1990; 43:27-38.
13. Scharfstein J, Schmitz V, Morandi V et al. Host cell invasion by Trypanosoma cruzi is potentiated by activation of bradykinin B(2) receptors. J Exp Med 2000; 192:1289-300.
14. Todorov AG, Andrade D, Pesquero JB et al. Trypanosoma cruzi induces edematogenic responses in mice and invades cardiomyocytes and endothelial cells in vitro by activating distinct kinin receptor (B1/B2) subtypes. FASEB J 2003; 17:73-5.
15. Monteiro AC, Schmitz V, Morrot A et al.BradykininB2receptors of dendritic cells, acting as sensors of kinins proteolytically released by Trypanosoma cruzi, are critical for the development of protective type-1 responses. PLoS Pathog 2007; 3:e185.
16. Monteiro AC, Schmitz V, Svensjo E et al. Cooperative activation of TLR2 and bradykinin B2 receptor is required for induction of type 1 immunity in a mouse model of subcutaneous infection by Trypanosoma cruzi. J Immunol 2006; 177:6325-35.
17. Souza PE, Rocha MO, Rocha-Vieira E et al. Monocytes from patients with indeterminate and cardiac forms of Chagas' disease display distinct phenotypic and functional characteristics associated with morbidity. Infect Immun 2004; 72:5283-91.
18. Jensen PE. Recent advances in antigen processing and presentation. Nat Immunol 2007; 8:1041-8.
19. Friedland J, Setton C, Silverstein E. Induction of angiotensin converting enzyme in human monocytes in culture. Biochem Biophys Res Commun 1978; 83:843-9.
20. Shen XZ, Lukacher AE, Billet S, Williams IR, Bernstein KE. Expression of angiotensin-converting enzyme changes major histocom-patibility complex class I peptide presentation by modifying C termini of peptide precursors. J Biol Chem 2008; 283:9957-65.
21. Costerousse O, Allegrini J, Lopez M, Alhenc-Gelas F. Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem J 1993; 290:33-40.
22. Costa GC, da Costa Rocha MO, Moreira PR et al. Functional IL-10 gene polymorphism is associated with Chagas disease cardiomyopathy. J Infect Dis 2009; 199:451-4.
23. Roberti RR, Martinez EE, Andrade JL et al. Chagas cardiomyopathy and captopril. Eur Heart J 1992; 13:966-70.
24. Barbasz A, Kozik A. The assembly and activation of kinin-forming systems on the surface of human U-937 macrophage-like cells. Biol Chem 2009; 390:269-75.
25. Godsel LM, Leon JS, Wang K, Fornek JL, Molteni A, Engman DM. Captopril prevents experimental autoimmune myocarditis. J Immunol 2003; 171:346-52.
26. Hooper NM. Angiotensin converting enzyme: implications from molecular biology for its physiological functions. Int J Biochem 1991; 23:641-7.
27. Saijonmaa O, Nyman T, Fyhrquist F. Atorvastatin inhibits angiotensin-converting enzyme induction in differentiating human macrophages. Am J Physiol Heart Circ Physiol 2007; 292:H1917-21.
28. Danilov SM, Sadovnikova E, Scharenborg N et al. Angiotensin-converting enzyme (CD143) is abundantly expressed by dendritic cells and discriminates human monocyte-derived dendritic cells from acute myeloid leukemia-derived dendritic cells. Exp Hematol 2003; 31:1301-9.
29. Schindler R, Dinarello CA, Koch KM. Angiotensin-converting-enzyme inhibitors suppress synthesis of tumour necrosis factor and interleukin 1 by human peripheral blood mononuclear cells. Cytokine 1995; 7:526-33.
30. Shen XZ, Li P, Weiss D et al. Mice with enhanced macrophage angiotensin-converting enzyme are resistant to melanoma. Am J Pathol 2007; 170:2122-34.
31. Constantinescu CS, Goodman DB, Ventura ES. Captopril and lisinopril suppress production of interleukin-12 by human peripheral blood mononuclear cells. Immunol Lett 1998; 62:25-31.
32. Odaka C, Mizuochi T. Angiotensin-converting enzyme inhibitor captopril prevents activation-induced apoptosis by interfering with T cell activation signals. Clin Exp Immunol 2000; 121:515-22.
33. Deas O, Dumont C, Mollereau B et al. Thiol-mediated inhibition of FAS and CD2 apoptotic signaling in activated human peripheral T cells. Int Immunol 1997; 9:117-25.
34. Harrington LE, Hatton RD, Mangan PR et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005; 6:1123-32.
35. Tesmer LA, Lundy SK, Sarkar S, Fox DA. Th17 cells in human disease. Immunol Rev 2008; 223:87-113.
36. Bacellar O, Faria D, Nascimento M et al. Interleukin 17 production among patients with American cutaneous leishmaniasis. J Infect Dis 2009; 200:75-8.
37. da Matta Guedes PM, Gutierrez FR, Maia FL et al. IL-17 produced during Trypanosoma cruzi infection plays a central role in regulating parasite-induced myocarditis. PLoS Negl Trop Dis 2010; 4:e604.
38. Monteiro AC, Scovino A, Raposo S et al. Kinin danger signals proteolytically released by gingipain induce Fimbriae-specific IFN-gamma- and IL-17-producing T cells in mice infected intramucosally with Porphyromonas gingivalis. J Immunol 2009; 183:3700-11.